Acute Kidney Injury Associated With Remdesivir: A Comprehensive Pharmacovigilance Analysis of COVID-19 Reports in FAERS

Acute kidney injury (AKI) is a common complication among patients with the novel coronavirus (COVID-19). COVID-19 along with AKI usually resulted in a poor prognosis for those affected. Remdesivir is a novel antiviral drug that was urgently approved for the treatment of COVID-19. In the current stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Bin, Luo, Min, Wu, Fengbo, He, Zhiyao, Li, Yuwen, Xu, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990823/
https://www.ncbi.nlm.nih.gov/pubmed/35401177
http://dx.doi.org/10.3389/fphar.2022.692828

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990823/
https://www.ncbi.nlm.nih.gov/pubmed/35401177
http://dx.doi.org/10.3389/fphar.2022.692828

Ejemplares similares